Long-Term Survival of Primary Intracranial Plasmablastic Lymphoma: Case Report and Review of the Literature.
Sign Up to like & getrecommendations! Published in 2017 at "World neurosurgery"
DOI: 10.1016/j.wneu.2016.10.098
Abstract: BACKGROUND Primary intracranial plasmablastic lymphoma (PIPBL) is a rare malignant tumor. CASE DESCRIPTION We present a case of PIPBL in a 32-year-old man who complained of a progressive growing, painful mass on the right parieto-occipital… read more here.
Keywords: literature; plasmablastic lymphoma; primary intracranial; intracranial plasmablastic ... See more keywords
Human Immunodeficiency Virus Associated Plasmablastic Lymphoma Involving Bones and Peritoneum in a 4-Year-old Child.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002534
Abstract: In children with underlying Human Immunodeficiency virus infection and AIDS, hematolymphoid cancers, especially non-hodgkin lymphomas are common. Plasmablastic lymphoma is one such non-hodgkin lymphomas arising from the head and neck region (especially sinonasal) but extremely… read more here.
Keywords: plasmablastic lymphoma; lymphoma; immunodeficiency virus; year old ... See more keywords
SLAMF7 (CD319/CS1) is expressed in plasmablastic lymphoma and is a potential diagnostic marker and therapeutic target
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15393
Abstract: The plasmablastic lymphomas (PBLs) are a group of aggressive B cell neoplasms that share pathobiological features with large B cell lymphoma (LBCL) and plasma cell myeloma. They are characterized by a diffuse proliferation of large… read more here.
Keywords: lymphoma; plasmablastic lymphoma; cd319 cs1; slamf7 cd319 ... See more keywords
Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?—Potential therapeutic applications
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Haematology"
DOI: 10.1111/ejh.13584
Abstract: Plasmablastic lymphoma (PBL) is a rare but aggressive lymphoma that usually occurs in HIV-positive patients but can also affects immunocompetent individuals.1 The prognosis of patients with PBL is poor. Due to its rarity, no standard… read more here.
Keywords: could daratumumab; daratumumab induce; plasmablastic lymphoma; maturation plasmablasts ... See more keywords
High incidence of MYC rearrangement in human immunodeficiency virus‐positive plasmablastic lymphoma
Sign Up to like & getrecommendations! Published in 2019 at "Histopathology"
DOI: 10.1111/his.13959
Abstract: MYC rearrangements are the main cytogenetic alterations in plasmablastic lymphoma (PBL). We aimed to investigate the relationship between MYC rearrangement and the clinicopathological features of PBL. read more here.
Keywords: high incidence; myc rearrangement; plasmablastic lymphoma;
Plasmablastic lymphoma: An update
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Laboratory Hematology"
DOI: 10.1111/ijlh.13863
Abstract: Plasmablastic lymphoma (PBL) is a highly aggressive B cell non‐Hodgkin lymphoma frequently associated with immunosuppression, particularly human immunodeficiency virus (HIV) infection. Although PBL is rare globally, South Africa has a high burden of HIV infection… read more here.
Keywords: laboratory; plasmablastic lymphoma; cell; lymphoma ... See more keywords
Plasmablastic lymphoma masquerading solitary plasmacytoma in an immunocompetent patient
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Case Reports"
DOI: 10.1136/bcr-2018-225374
Abstract: We report a case of a middle-aged woman who initially presented with a painful solitary destructive lesion at fifth lumbar vertebra. The initial diagnosis of plasma cell neoplasm was made based on limited histological information… read more here.
Keywords: solitary plasmacytoma; lymphoma masquerading; plasmablastic lymphoma; masquerading solitary ... See more keywords
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma
Sign Up to like & getrecommendations! Published in 2023 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2023-006684
Abstract: Plasmablastic lymphoma (PBL) is a rare subtype of aggressive large B-cell lymphoma, with a dismal prognosis despite aggressive therapies. New approaches are needed for those with refractory disease. PBL expresses antigens similar to multiple myeloma… read more here.
Keywords: car; plasmablastic lymphoma; cell; bcma car ... See more keywords
Plasmablastic Lymphoma Presenting as Extensive Peritoneal and Retroperitoneal Nodules in an HIV-Positive Patient
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Investigative Medicine High Impact Case Reports"
DOI: 10.1177/23247096211065633
Abstract: Plasmablastic lymphoma (PBL) is a rare but aggressive subtype of diffuse large B-cell lymphoma (DLBCL). The diagnosis of PBL is challenging as its features overlap with lymphoma and myeloma. The most common presentation involves the… read more here.
Keywords: hiv positive; plasmablastic lymphoma; retroperitoneal nodules; peritoneal retroperitoneal ... See more keywords
Clinicopathologic Comparison of Plasmablastic Lymphoma Patients According HIV-Status: Peruvian Experience
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-142239
Abstract: Background:Plasmablastic lymphoma (PBL) is an aggressive lymphoma associated mainly to HIV infection, although cases in immunocompetent patients are described as well. Objective:To describe the clinicopathologic features and determine the overall survival of lymphoma patients according… read more here.
Keywords: status; plasmablastic lymphoma; hiv; hiv negative ... See more keywords
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
Sign Up to like & getrecommendations! Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2021005486
Abstract: Plasmablastic-lymphoma (PBL) represents a clinically heterogeneous subtype of aggressive-B-cell-non-Hodgkin-lymphoma. Although targeted-sequencing-studies and a single-center whole-exome-sequencing (WES) study in HIV+ patients recently revealed several genes, associated with PBL-pathogenesis, the global mutational-landscape and transcriptional-profile of PBL remain… read more here.
Keywords: lymphoma; integrative genomic; plasmablastic lymphoma; analysis ... See more keywords